19 results on '"Lubbert M."'
Search Results
2. Prompt differentiation of a rare subset of human hematopoietic cells (HSC) stimulated by multiple cytokines in vitro: 297
3. Effect of 5-aza-2ʼ-deoxycytidine (DAC) on proliferating normal human CD34+ cells: a model to study demethylation during myeloid differentiation: 298
4. Long term follow up of elderly patients with Philadelphia-Positive Acute Lymphoblastic Leukaemia (Ph plus ALL) : Updated results of the GMALL elderly trials
5. CD34+ or CD34-: which is the more primitive?
6. 166 Safety of panobinostat plus 5-azacitidine in myelodysplastic syndrome, chronic myelomonocytic leukemia, or acute myeloid leukemia patients: a phase Ib study
7. Acquired alpha-thalassaemia in association with myelodysplastic syndrome (ATMDS): Two further private ATRX mutations
8. 34 Which myelodysplastic syndromes patients are candidates for treatment with decitabine?
9. P-108 Re-treatment results insecond remission of MDS with previous response to low-dose 5-aza-2′-deoxycytidine (decitabine)
10. P-10 Influence of age and gender on survival in MDS: Importance of an IPSS *gender interaction — A multicenter analysis on 1159 patients
11. O-54 Epigenetic therapy for MDS
12. O-33 Cryogenetic profile in 2124 patientswith MDS — Correlations with morphology, clinical course and prognosis
13. O-22 Incidence of cytogenetic response in MDS/AML patients with complex karyotype receiving low-dose 5-aza-2′deoxycytidine (decitabine) treatment
14. Interleukin-4 Inhibits Growth of Multiple Myelomas by Suppressing Interleukin-6 Expression
15. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial
16. P-10 Influence of age and gender on survival in MDS: Importance of an IPSS*gender interaction — A multicenter analysis on 1159 patients
17. Netboost: Boosting-Supported Network Analysis Improves High-Dimensional Omics Prediction in Acute Myeloid Leukemia and Huntington's Disease.
18. Long-term results of all-trans retinoic acid and arsenic trioxide in non-high-risk acute promyelocytic leukemia: update of the APL0406 Italian-German randomized trial.
19. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.